Pemetrexed, a DHFR and thymidylate synthase inhibitor, activates AMPK and inhibits mTOR signaling pathway by synergizing with temozolomide (TMZ) to obstruct tumor growth [176]. The gene discussed is DHFR; the disease is neoplasm.